LNWWM
DCOY

Laird Norton Wetherby Wealth Management’s Decoy Therapeutics DCOY Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed -$8K – 952
2022
Q3 		$8K Hold
1
– – ﹤0.01% 882
2022
Q2 		$8K Hold
1
– – ﹤0.01% 903
2022
Q1 		$16K Hold
1
– – ﹤0.01% 927
2021
Q4 		$20K Hold
1
– – ﹤0.01% 928
2021
Q3 		$41K Hold
1
– – ﹤0.01% 927
2021
Q2 		$42K Hold
1
– – ﹤0.01% 926
2021
Q1 		$59K Hold
1
– – ﹤0.01% 779
2020
Q4 		$36K Hold
1
– – ﹤0.01% 902
2020
Q3 		$34K Hold
1
– – ﹤0.01% 718
2020
Q2 		$52K Hold
1
– – ﹤0.01% 708
2020
Q1 		$27K Hold
1
– – ﹤0.01% 677
2019
Q4 		$150K Hold
1
– – 0.01% 682
2019
Q3 		$271K Buy
+1
New +$341K 0.03% 577

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return